Overview

Bioequivalency Study of Imipramine Pamoate 75 mg Capsules Under Fasted Conditions

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to prove the bioequivalence of Imipramine Pamoate 75 mg Capsules under fasting conditions
Phase:
N/A
Details
Lead Sponsor:
Roxane Laboratories
Treatments:
Imipramine